TITLE

FIBRINOLYSIS AND ATHEROSCLEROSIS

AUTHOR(S)
Berry, Perrin L.
PUB. DATE
May 1962
SOURCE
Angiology;May1962, Vol. 13 Issue 5, p208
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Because of seemed logical to expect a difference between the fibrinolytic activity in the blood of patients suffering from complications of atherosclerosis and of subjects having no evidence of the disease, two such groups have been studied. Plasminogen, plasminogen activator and inhibitor activity were assayed by techniques measuring proteolytic activity of plasma. No differences between the two groups could be demonstrated.
ACCESSION #
16370347

 

Related Articles

  • STUDIES ON FIBRINOLYTIC ACTIVITY IN NORMAL PERSONS AND PATIENTS WITH ATHEROSCLEROTIC VASCULAR DISEASE AFTER PHYSICAL ACTIVITY AND INJECTIONS OF NICOTINIC ACID. Laursen, Benedicte; Gormsen, Johs. // Angiology;Jul/Aug1970, Vol. 21 Issue 7, p486 

    The fibrinolytic activity was studied in fiftyone normal individuals and patients with atheroselerotic vascular disease after physical exertion or injections of nicotinic acid. All groups showed equal reactivity to the stimuli given, judged by acceleration of euglobnlin clot lysis, but in none...

  • Targeting the prevention of plaque rupture as a new strategy for prevention of acute arterial cardiovascular events. Levi, Marcel; Stroes, Erik // Cardiovascular Research;Jun2008, Vol. 78 Issue 3, p407 

    An editorial is presented which discusses the study "Differential Effects of PARP Inhibition on Vascular Cell Survival and ACAT-1 Expression Favouring Atherosclerotic Plaque Stability." The author explain the causes of acute arterial cardiovascular disorders. They consider the prevention and...

  • Elucidating atherosclerotic vulnerable plaque rupture by modeling cross substitution of ApoE mouse and human plaque components stiffnesses. Ohayon, Jacques; Mesnier, Nicolas; Broisat, Alexis; Toczek, Jakub; Riou, Laurent; Tracqui, Philippe // Biomechanics & Modeling in Mechanobiology;Jul2012, Vol. 11 Issue 6, p801 

    The structure of mouse atherosclerotic lesions may differ from that of humans, and mouse atherosclerotic plaques do not rupture except in some specific locations such as the brachiocephalic artery. Recently, our group was the first to observe that the amplitudes of in vivo stresses in ApoE mouse...

  • Artery Explorer hitting the road again. M. A. // Medical Marketing & Media;May2009, Vol. 44 Issue 5, p27 

    The article reports on the second tour of the Artery Explorer from Astrazeneca in the U.S. It notes that the Artery Explorer, a truck-mounted which is equipped with fiberglass pod aims to help bring atherosclerosis to life. It also shows an animated plaque attack to patients and is considered as...

  • THROMBOSIS AS A FACTOR IN ATHEROSCLEROSIS. French, John E. // Angiology;Aug1966, Vol. 17 Issue 8, p590 

    In addition to the well-recognized occurrence of thrombosis as a late complication of atherosclerosis, there is now good evidence that recurrent mural thrombosis is an important factor in the progress of many lesions from a relatively early stage. Many of the typical features of the lesion may...

  • Differential Regulation of Matrix Metalloproteinase-9 and Tissue Plasminogen Activator Activity by the Cyclic-AMP System in Lipopolysaccharide-stimulated Rat Primary Astrocytes. Soon Lee; Hee Kim; Woo Lee; So Joo; Se-Jin Jeon; Ji Kim; Seol-Heui Han; Jongmin Lee; Seung Park; Jae Cheong; Won-Ki Kim; Kwang Ko; Chan Shin // Neurochemical Research;Nov2008, Vol. 33 Issue 11, p2324 

    Abstract  We investigated the effect of the cAMP system on lipopolysaccharide (LPS)-induced changes in the activity of matrix metalloproteinases (MMPs) and tissue plasminogen activator (tPA) in rat primary astrocytes. LPS stimulation increased MMP-9 and decreased tPA activity in rat...

  • Plasminogen-related.  // Encyclopedic Reference of Cancer;2001, p701 

    A definition of the term "plasminogen-related protein" is presented. It refers to a protein that shares structural similarity and evolutionary relationship with plasminogen.

  • Accelerated atheroma and anti �2-glycoprotein I antibodies. Matsuura, E.; Koike, T. // Lupus;2000, Vol. 9 Issue 3, p210 

    Examines the possible involvement of auto-antibodies against anti-beta2- glycoprotein in accelerated atherosclerosis. Serological reactivity of antiphospholipid antibodies and anti-beta2-glycoprotein I antibodies; Biological nature and antigenicity of beta2-glycoprotein I; Oxidative...

  • DISCUSSION. Sanchez, Luis A. // Vascular Surgery;Mar/Apr1997, Vol. 31 Issue 2, p161 

    Comments on a study by Phillip J. Bendick et al on the arterial adaptation to increased wall shear stress. Factor associated with the development of atherosclerotic plaques; Purpose of the technique used in non-atherogenic model.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics